Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery

NCT00858936 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Study Terminated - Company decision

Conditions

Coronary Artery Bypass Surgery

Interventions

DRUG: IK-1001
DRUG: Normal Saline

Sponsor

Mallinckrodt